Keith Katkin

Insider Reports History

Location
C/O Urovant Sciences, Inc., 5281 California Avenue, Suite 100, Irvine, CA
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keith Katkin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eledon Pharmaceuticals, Inc. Director Stock Option (right to buy) 77.2K $1.17M $1.55 Jan 10, 2025 Direct
Syndax Pharmaceuticals Inc Director Common Stock 100K $911K $9.11 May 19, 2025 Direct
Emergent BioSolutions Inc. Director Common Stock 86.4K $545K $6.30 May 23, 2025 Direct
RIGEL PHARMACEUTICALS INC Director Common Stock 25K $43.8K $1.75 May 19, 2021 Direct
Emergent BioSolutions Inc. Director Stock Option (Right to Buy) 41.6K Apr 30, 2025 Direct
RIGEL PHARMACEUTICALS INC Director Stock Option (Right to Buy) 30K May 19, 2021 Direct
Eledon Pharmaceuticals, Inc. Director Restricted Stock Units 8.58K Jan 10, 2025 Direct

Insider Reports Filed by Keith Katkin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EBS Emergent BioSolutions Inc. May 23, 2025 1 -$49.4K 4 May 28, 2025 Director
SNDX Syndax Pharmaceuticals Inc May 19, 2025 1 $91.1K 4 May 19, 2025 Director
EBS Emergent BioSolutions Inc. Apr 30, 2025 2 $0 4 May 2, 2025 Director
SNDX Syndax Pharmaceuticals Inc Feb 5, 2025 1 $0 4 Feb 7, 2025 Director
ELDN Eledon Pharmaceuticals, Inc. Jan 10, 2025 2 $0 4 Jan 13, 2025 Director
EBS Emergent BioSolutions Inc. May 23, 2024 2 $0 4 May 28, 2024 Director
SNDX Syndax Pharmaceuticals Inc Feb 7, 2024 1 $0 4 Feb 9, 2024 Director
EBS Emergent BioSolutions Inc. May 25, 2023 1 $0 4 May 30, 2023 Director
ELDN Eledon Pharmaceuticals, Inc. May 1, 2023 1 $0 4 May 2, 2023 Director
SNDX Syndax Pharmaceuticals Inc Feb 2, 2023 1 $0 4 Feb 3, 2023 Director
ELDN Eledon Pharmaceuticals, Inc. Feb 1, 2023 1 $0 4 Feb 2, 2023 Director
SNDX Syndax Pharmaceuticals Inc Oct 6, 2022 6 -$529K 4 Oct 7, 2022 Director
SNDX Syndax Pharmaceuticals Inc Sep 30, 2022 18 -$69.5K 4 Oct 4, 2022 Director
EBS Emergent BioSolutions Inc. Apr 2, 2022 1 $0 4 Apr 5, 2022 Director
EBS Emergent BioSolutions Inc. Apr 1, 2022 0 $0 3 Apr 5, 2022 Director
SNDX Syndax Pharmaceuticals Inc Feb 2, 2022 1 $0 4 Feb 3, 2022 Director
ELDN Eledon Pharmaceuticals, Inc. Feb 1, 2022 1 $0 4 Feb 2, 2022 Director
RIGL RIGEL PHARMACEUTICALS INC May 19, 2021 2 $0 4 May 21, 2021 Director